Vaxart News

Company Name Stock Ticker Symbol Market Type
Vaxart Inc VXRT NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.01 0.81% 1.25 08:07:41
Open Price Low Price High Price Close Price Prev Close
more quote information »

Recent News

Date Time Source Heading
11/22/202208:30GLOBEVaxart to Present at World Vaccine & Immunotherapy Congress..
11/08/202216:01GLOBEVaxart Provides Business Update and Reports Third Quarter..
10/20/202208:30GLOBEVaxart to Host Third Quarter 2022 Business Update and..
10/10/202208:00GLOBEVaxart to Present at World Vaccine Congress Europe 2022 on..
10/07/202217:32EDGARStatement of Changes in Beneficial Ownership (4)
9/07/202208:30GLOBEVaxart to Present at the H.C. Wainwright 24th Annual Global..
9/02/202207:21TRMNAnalysts Offer Insights on Healthcare Companies: Mesoblast..
9/01/202206:30GLOBEVaxart Announces Positive Top-line Phase II Clinical Study..
8/31/202216:30GLOBEVaxart to Host Conference Call on September 1 at 8:30 AM ET..
8/31/202208:30GLOBEVaxart Names Biotech Veteran Ray Stapleton Chief Technology..
8/26/202215:51EDGARStatement of Changes in Beneficial Ownership (4)
8/25/202217:07EDGARStatement of Changes in Beneficial Ownership (4)
8/25/202217:06EDGARInitial Statement of Beneficial Ownership (3)
8/25/202216:09EDGARCurrent Report Filing (8-k)
8/25/202216:05GLOBEVaxart Announces Highly Regarded Biotech Executive Elaine J...
8/22/202218:06EDGARStatement of Changes in Beneficial Ownership (4)
8/11/202209:45TRMNB.Riley Financial Keeps Their Hold Rating on Vaxart (VXRT)
8/08/202220:25TRMNVaxart (VXRT) Receives a New Rating from Brookline Capital..
8/08/202218:39EDGARStatement of Changes in Beneficial Ownership (4)
8/08/202218:36EDGARStatement of Changes in Beneficial Ownership (4)
8/08/202218:32EDGARStatement of Changes in Beneficial Ownership (4)
8/08/202218:23EDGARStatement of Changes in Beneficial Ownership (4)
8/08/202218:17EDGARInitial Statement of Beneficial Ownership (3)
8/08/202216:07EDGARCurrent Report Filing (8-k)
8/08/202216:01GLOBEVaxart Provides Business Update and Reports Second Quarter..
8/08/202208:00GLOBEVaxart Appoints W. Mark Watson to its Board of Directors
8/05/202208:00GLOBEVaxart Stockholders Approve Proxy Proposals 2, 3 and 4
7/28/202216:05GLOBEVaxart to Host Second Quarter 2022 Business Update and..
7/28/202208:01EDGARCurrent Report Filing (8-k)
7/27/202208:00GLOBEVaxart Provides New Update on Proxy Voting and Urges All..
7/26/202211:12EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
7/20/202208:30GLOBEVaxart Publishes Clinical Data Suggesting its Oral COVID-19..
7/14/202208:00GLOBEVaxart to Present Preclinical and Clinical Data From Its..
7/12/202216:04EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
7/08/202216:16EDGARCurrent Report Filing (8-k)
7/06/202216:02EDGARCurrent Report Filing (8-k)
7/01/202217:28EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
7/01/202209:00GLOBEVaxart Provides an Update on Proxy Voting and Urges All..
6/30/202208:00GLOBEVaxart Announces Agreement with hVIVO to Develop World’s..
6/16/202216:07EDGARCurrent Report Filing (8-k)
6/16/202216:05GLOBEVaxart to Host Investor Q&A Webcast
6/08/202216:07EDGARCurrent Report Filing (8-k)
6/08/202209:05GLOBEVaxart Announces Adjournment of Annual Meeting of..
6/03/202208:00GLOBENew Preclinical Data Demonstrate Two of Vaxart’s COVID-19..
6/02/202211:55TRMNBrookline Capital Markets Thinks Vaxart’s Stock is Going to..
6/02/202208:30GLOBEVaxart Reports Positive Preliminary Data from the Phase 1b..
6/02/202208:00GLOBEVaxart to Participate at the Jefferies Global Healthcare..
5/25/202217:04EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
5/20/202215:33TRMNVaxart Has Great News if You’re Afraid of Covid-19 — And..
5/19/202208:30GLOBEVaxart Announces the Publication of Studies in the..